Elyon Pharmaceuticals Private Limited
About Elyon Pharmaceuticals Private Limited
Data last updated:
Elyon Pharmaceuticals Private Limited is a private limited company based in Delhi, India. It operates in the medicinal chemical and botanical products segment of the chemicals sector. It was incorporated on 08 May 2013 and has been in existence for over 13 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24297DL2013PTC251805. Its GSTIN is 07AADCE3762H1ZO (Delhi). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹30 Lakh and a paid-up capital of ₹16.13 Lakh. It is led by directors including Bijay Kumar Kejriwal and Arvind Kejriwal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at D – 121 1st Floor Phase – 1, Ashok Vihar Delhi – 110052, Delhi, India – 110052.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.24 Cr, a decline of 41% compared to the previous year. For the same year it recorded a net profit of ₹11.26 Lakh (net margin 9.1%) and EBITDA of ₹13.6 Lakh (EBITDA margin 11%). Revenue has grown at a compounded annual rate (CAGR) of 20% over three years and 18% over five years.
Court records list 1 case involving the company, including 1 filed by the company.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Elyon Pharmaceuticals Private Limited's registered office is in Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressD – 121 1st Floor Phase – 1, Ashok Vihar Delhi – 110052, Delhi, India – 110052
- IndustryChemicals, Medicinal Chemical & Botanical Products, Pharmaceuticals, Chemical Products
To see the full contact details of Elyon Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Elyon Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Elyon Pharmaceuticals Private Limited, buy the company report.
Financials of Elyon Pharmaceuticals Private Limited
FY 2025 filings availableElyon Pharmaceuticals Private Limited reported revenue of ₹1.24 Cr (down 41% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 41% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 18%. EBITDA rose 236% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹13.6 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹11.26 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 11% | ||||
| Net Profit Margin | 9.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Elyon Pharmaceuticals Private Limited, buy the company report.
Board of directors of Elyon Pharmaceuticals Private Limited
Elyon Pharmaceuticals has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Bijay Kumar Kejriwal | Director | 08 May 2013 | 13 Years 5 Months | Current |
| Arvind Kejriwal | Director | 08 May 2013 | 13 Years 5 Months | Current |
| Aditya Kejriwal | Director | 08 May 2013 | 13 Years 5 Months | Current |
Auditor
Elyon Pharmaceuticals Private Limited is audited by K K BARANWAL & ASSOCIATES for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| K K BARANWAL & ASSOCIATES | FY 2017 | 024207N |
Shareholding
The shareholding of Elyon Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Elyon Pharmaceuticals Private Limited, buy the company report.
Legal cases
Elyon Pharmaceuticals Private Limited has 1 court case on record: 1 filed by Elyon Pharmaceuticals. All case is disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 1 | 0 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court of Delhi | Court case (C.A.(COMM.IPD-TM)) | Filed by the company against The Registrar of Trademarks | Disposed |
To see the full case history of Elyon Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Elyon Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Elyon Pharmaceuticals has 2 GST registrations: 2 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AADCE3762H1ZO | Delhi | Active | 01 Jul 2017 |
| 18AADCE3762H1ZL | Assam | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Elyon Pharmaceuticals Private Limited, buy the company report.
Recent activity
Elyon Pharmaceuticals Private Limited has 3 board changes on record since 2013: 3 appointments. The latest: Aditya Kejriwal was appointed as Director on 08 May 2013.
Frequently asked questions
Elyon Pharmaceuticals is an active private limited company based in Delhi, India. The company works in medicinal chemical and botanical products, within the chemicals industry. It was incorporated on 08 May 2013 (13+ years old) and is registered under CIN U24297DL2013PTC251805.
Elyon Pharmaceuticals has 3 current directors:
- Bijay Kumar Kejriwal - Director
- Arvind Kejriwal - Director
- Aditya Kejriwal - Director
The latest financial statements of Elyon Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Elyon Pharmaceuticals is 07AADCE3762H1ZO, registered in Delhi. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 18AADCE3762H1ZL (Assam).
The CIN (Corporate Identification Number) of Elyon Pharmaceuticals is U24297DL2013PTC251805. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Elyon Pharmaceuticals has 1 court case on record: 1 filed by the company.
Elyon Pharmaceuticals was incorporated on 08 May 2013, making it 13+ years old. It is registered with the Registrar of Companies, Delhi.
Aditya Kejriwal was appointed as Director on 08 May 2013. Arvind Kejriwal was appointed as Director on 08 May 2013. Bijay Kumar Kejriwal was appointed as Director on 08 May 2013.
The registered office of Elyon Pharmaceuticals is at D – 121 1st Floor Phase – 1, Ashok Vihar Delhi – 110052, Delhi, India – 110052.
Elyon Pharmaceuticals operates in the chemicals industry, in the medicinal chemical and botanical products segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
